PATRICIA SALVATO: Open Payments
NPI 1043218845 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,402 in 86 payments from 21 companies in 2025. Trend: 2023 $1,668 · 2024 $1,180 · 2025 $1,402
Food & beverage: $1,402
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 12 | $273 |
| PFIZER INC. | 9 | $149 |
| AstraZeneca Pharmaceuticals LP | 6 | $149 |
| ABBVIE INC. | 25 | $146 |
| Novo Nordisk Inc | 6 | $141 |
| Merck Sharp & Dohme LLC | 7 | $136 |
| EMD Serono, Inc. | 5 | $115 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $32 |
| Antares Pharma, Inc. | 2 | $28 |
| Renalytix AI, Inc. | 1 | $28 |
Products named: NURTEC ODT, AIRSUPRA, PIFELTRO, Ozempic, CABENUVA, VRAYLAR, APRETUDE, DOVATO.
Industry payments across TX — which companies pay providers there.
